160 related articles for article (PubMed ID: 18393805)
1. Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
Vincent B; Cisse MA; Sunyach C; Guillot-Sestier MV; Checler F
Curr Alzheimer Res; 2008 Apr; 5(2):202-11. PubMed ID: 18393805
[TBL] [Abstract][Full Text] [Related]
2. α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.
Guillot-Sestier MV; Sunyach C; Ferreira ST; Marzolo MP; Bauer C; Thevenet A; Checler F
J Biol Chem; 2012 Feb; 287(7):5021-32. PubMed ID: 22184125
[TBL] [Abstract][Full Text] [Related]
3. Control of amyloid-beta-peptide generation by subcellular trafficking of the beta-amyloid precursor protein and beta-secretase.
Walter J
Neurodegener Dis; 2006; 3(4-5):247-54. PubMed ID: 17047364
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.
Checler F; Vincent B
Trends Neurosci; 2002 Dec; 25(12):616-20. PubMed ID: 12446128
[TBL] [Abstract][Full Text] [Related]
5. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
6. ADAM proteases: protective role in Alzheimer's and prion diseases?
Vincent B
Curr Alzheimer Res; 2004 Aug; 1(3):165-74. PubMed ID: 15975064
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
8. ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε.
Cisse M; Braun U; Leitges M; Fisher A; Pages G; Checler F; Vincent B
Mol Cell Neurosci; 2011 Jul; 47(3):223-32. PubMed ID: 21570469
[TBL] [Abstract][Full Text] [Related]
9. Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease.
Bandyopadhyay S; Goldstein LE; Lahiri DK; Rogers JT
Curr Med Chem; 2007; 14(27):2848-64. PubMed ID: 18045131
[TBL] [Abstract][Full Text] [Related]
10. Epsilon-secretase: reduction of amyloid precursor protein epsilon-site cleavage in Alzheimer's disease.
Kametani F
Curr Alzheimer Res; 2008 Apr; 5(2):165-71. PubMed ID: 18393801
[TBL] [Abstract][Full Text] [Related]
11. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.
Agostinho P; Pliássova A; Oliveira CR; Cunha RA
J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722
[TBL] [Abstract][Full Text] [Related]
12. [Production and catabolism of amyloid peptides in Alzheimer's disease].
Checler F
Therapie; 2010; 65(5):409-14. PubMed ID: 21144475
[TBL] [Abstract][Full Text] [Related]
13. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
15. BACE1: the beta-secretase enzyme in Alzheimer's disease.
Vassar R
J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells.
Dey A; Chen R; Li F; Maitra S; Hernandez JF; Zhou GC; Vincent B
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946739
[TBL] [Abstract][Full Text] [Related]
17. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
18. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
